Management of diabetes in pregnancy: comparison of guidelines with current practice at Austrian and Australian obstetric center

Aim

To compare Austrian and Australian national guidelines for gestational and pre-gestational diabetes and estimate the level to which physicians comply with their country’s guidelines.

Methods

Austrian (ÖDG, Austrian Diabetes Society) and Australian guidelines (ADIPS, Australasian Diabetes in Pregnancy Society) for the treatment of gestational diabetes and pre-gestational diabetes were systematically reviewed. Current practices in two obstetric centers in Austria and Australia were assessed by interviewing key stakeholders through questionnaires assessing different components of diabetes care. For gestational diabetes, these components were screening, abnormal oral glucose tolerance test values (mmol/L), abnormal values for diagnosis, further management when abnormal values are detected, monitoring/glucose targets (mmol/L), further management and indications for insulin therapy, route and timing of delivery, and postpartum management and counseling. For pre-gestational diabetes, the components were management during the preconceptional period, glucose target values, medical surveillance, obstetric surveillance, medication used, route and timing of delivery, and postpartum management and counseling.

Results

More variation was found in the management of gestational than pre-gestational diabetes. There were differences in oral glucose tolerance test and cut-off levels for diagnosing gestational diabetes in both centers and guidelines. Australian guidelines recommended two-stage screening for gestational diabetes, while Austrian guidelines recommended one-stage screening. At the Austrian obstetric center, amniocentesis was recommended for determining the start of insulin treatment in pregnant women with gestational diabetes. This approach was neither used at the Australian obstetric center nor recommended by any of the two guidelines.

Conclusion

Our study showed that it was difficult to standardize screening criteria and diagnostic methods for gestational and pre-gestational diabetes. National and international consensus has yet to be achieved in the management of diabetes in pregnancy.The number of cases of diabetes worldwide has significantly increased in the last decade and it is expected to double by 2030 (1). This “diabetic epidemic” also considerably affects pregnant women (2). However, the management of pre-gestational and gestational diabetes, the latter being defined as glucose intolerance first detected in pregnancy, remains controversial (3). Gestational and pre-gestational diabetes are associated with increased feto-maternal morbidity, including stillbirth, macrosomia, and fetal malformations, as well as long-term complications in the mother and offspring (4-6). However, treatment and/or monitoring reduce perinatal mortality to the rate in the healthy population. There is no internationally agreed approach and there are neither up-to-date World Health Organization (WHO) recommendations nor fact sheets designed especially for diabetes in pregnancy. The complexity of gestational and pre-gestational diabetes, its underlying pathogenetic mechanism, and recent insights into potential and far-ranging complications have justified the establishment of a considerable number of recent national guidelines (7). Variation in treatment strategies has originated from different views, approaches, and traditional management in obstetric clinics around the globe.As a novelty, this study does not only compare national guidelines of Austria and Australia, two developed high-income countries situated on different continents, but also estimates the level to which physicians comply with their country’s guidelines. Since currently no international standardized approach to screening criteria and diagnostic methods for gestational diabetes and pre-gestational diabetes exists and opinions differ even on the national level, we hypothesized that there were major differences in screening, diagnosing, and treating diabetes in pregnancy. An additional aim of this study was to produce a table of requirements that should be incorporated into future guidelines.     

Assessment of fetal gestational age in different trimesters from ultrasonographic measurements of various fetal biometric parameters

Introduction: Fetal biometry is a methodology devoted to measuring several parts of fetal anatomy and their growth. Aim: The present study was carried out to assess gestational age in the second and third trimesters with the help of ultrasonographic measurements of four fetal biometric parameters (i.e., biparietal diameter [BPD], head circumference [HC], abdominal circumference [AC], and femur length [FL]) in the local population (Jaipur Zone) of Rajasthan, and also to evaluate efficacy and significance of these four fetal biometric parameters in the prediction of gestational age by ultrasound. Materials and methods: Three hundred and thirty cases of normal pregnant females were studied (165 - second trimester [13–28 weeks] and 165 - third trimester [29–40 weeks]) with the known last menstrual period (LMP) and studied once during gestation. Results: Biparietal diameter and head circumference were found to be equally best predictors of gestational age and to determine the expected date of delivery (EDD) in the second trimester and BPD and FL in the third trimester. Abdominal circumference was the least accurate parameter in both trimesters. Variability in predicting gestational age (using all four parameters) was ±2 weeks in the second trimester and +2 to ?4 weeks in the third trimester. The accuracy decreased and variability increased as the pregnancy advanced from the second to third trimester. Mean measurements of fetal biometric parameters were found lower than Western monograms in each week of both trimesters. Conclusions: Variation in predicted gestational age by ultrasonography (USG) is attributed to the anthropometric difference between the two populations due to racial, genetic, nutritional, and socioeconomic factors. Therefore, population-specific measurements should be made to generate tables and regression equations for more precise reporting of gestational age and EDD by USG.     

Insulin in obstetrics: a main parameter in the management of pregnancy

Insulin plays a central role in human pregnancy. Maternal insulin sensitivity decreases with advancing gestation in order to provide glucose and possibly other nutrients for feto-placental growth and energy needs. Moreover, alterations of insulin metabolism are clearly involved in the development of gestational diabetes. In recent years, hyperinsulinaemia has been also proposed as a possible pathogenic factor in the development of gestational hypertension and preeclampsia; furthermore it has also been postulated that there is an involvement of insulin sensitivity in fetal growth restriction. These intriguing data have stimulated our interest in summarizing the physiopathological mechanisms by which the pancreatic hormone could be involved in obstetrics.     

Development of the fetal uterus between 19 and 38 weeks of gestation: in-utero ultrasonographic measurements.

In-utero assessment of the internal female genitalia is important for determination of fetal gender in fetuses with suspected genital tract anomalies. We therefore measured fetal uterine transverse width and circumference from 19 weeks of gestation until term, using transvaginal and transabdominal high-resolution ultrasound techniques in order to establish nomograms. A prospective, cross-sectional study on 180 normal singleton pregnancies was performed. Data were obtained for 140 normal fetuses. The mean +/- SD uterine width and circumference were 12.9 +/- 4.1 mm (95% confidence interval 12.1-13.7), and 40.2 +/- 12.5 mm (95% confidence interval 37.9-42.5) respectively. Uterine size as a function of gestational age was expressed by the regression equations: uterine width (mm) = 12.9 + 0.7 x gestational age (weeks), and uterine circumference (mm) = 40.2 + 2.1 x gestational age. The correlation coefficients, r = 0.885 and r = 0.888, for uterine width and circumference, by gestational age respectively, were highly statistically significant (P < 0.001). A nomogram of uterine width and circumference per gestational week, and the 95% prediction limits were defined. The present data offer baseline measurements of the fetal uterus that may allow intrauterine assessment of the female genital tract and associated fetal gender.     

Intensive glycemic control in diabetic pregnancy with intrauterine growth restriction is detrimental to fetus

Hyperglycemia during early pregnancy can lead to congenital malformations and/or spontaneous abortion while in the last few days of pregnancy it causes neonatal metabolic complications. Macrosomia is the most common complication and is due to maternal hyperglycemia in second and third trimester of pregnancy. In view of all these, intensive glycemic control of the mother is recommended throughout pregnancy. Intrauterine growth restriction (IUGR) is a well known complication of pre-gestational diabetic patients due to vasculopathy and is also seen in gestational diabetes mellitus (GDM) due to overinsulinisation. Hitherto there are no separate recommendations for glycemic targets in pregnant diabetic patients with IUGR. In presence of IUGR due placental vascular insufficiency, intensive glycemic control may deprive fetus of nutrition. Secondly frequent hypoglycemias which are inevitable complication of insulin treatment may further worsen the IUGR. In presence of IUGR, macrosomia is a rare possibility, and in such situation intensive glycemic control throughout pregnancy may not be justifiable and may actually be detrimental. Neonatal metabolic complications can be avoided by strict glycemic control during last two weeks of pregnancy.     

Sonographic measurement of ear length among normal fetuses of pregnant Igbo women in port Harcourt,Nigeria

BackgroundFetal ear length measurement has been associated with some clinical values: sonographic marker for chromosomal aneuploidy and for biometric estimation of fetal gestational age.ObjectivesTo establish a baseline reference value for fetal ear length and to assess relationship between fetal ear length and gestational age.MethodsEar length measurements were obtained prospectively from fetuses in 551 normal singleton pregnancies of 15 to 41 weeks gestation. Normal cases were defined as normal sonographic findings during examination plus normal infant post-delivery. The relationship between gestational age (GA) in weeks and fetal ear length (FEL) in millimeters were analyzed by simple linear regression. Correlation of FEL measurements with GA, biparietal diameter (BPD), Head circumference (HC), Abdominal Circumference (AC), Femur Length (FL) and maternal age (MA) were also obtained.ResultsLinear relationships were found between FEL and GA (FEL=0.872GA-2.972). There was a high correlation between FEL and GA (r = 0.837; P = .001). Good linear relationship and strong positive correlation were demonstrated between FEL and BPD, AC, HC, and FL (p<0.05).ConclusionThe result of this study provides normal baseline reference value for FEL. The study also showed good linear relationship and good correlation between FEL and fetal biometric measurements.     

Ultrasonographic estimation of fetal gestational age by fetal kidney length

Introduction: Fetal kidney length vs biparietal diameter (BPD) and femur length (FL) were comparatively evaluated and the role of fetal kidney length in estimating gestational age was determined in the second and third trimesters. Materials and methods: The study was carried out on 199 women with singleton uncomplicated pregnancies attending the outdoor patient department (OPD) for routine ultrasound fetal biometry. Fetal kidney length was measured biweekly, between 18 weeks and 38 weeks of gestation. Linear regression models for estimation of gestational age were derived from biometric indices (BPD and FL) and kidney length. Result: The earliest age at which fetal kidney could be seen sonographically was the 18th week of gestation with the mean kidney length of 12 ± 1.31 mm. The mean sonographic kidney length at the 38th week of gestation was 40.4 ± 1.71 mm, indicating that the mean fetal kidney length increases as pregnancy progresses from 18 weeks to 38 weeks of gestation. Conclusion: The best linear regression model for estimating fetal gestational age is femur length, kidney length, and biparietal diameter in that order, with standard error of ±3.85 days, ±8.04 days, and ±8.75 days, respectively.     

Anthropometry of Malawian live births between 35 and 41 weeks of gestation

The aim of this analysis was to construct cross-sectional gestational age specific percentile curves for birthweight, length, head and mid-arm circumference for Malawian babies, and to compare these percentiles with reference values for babies born to women with normal pregnancies, from a developed country. A cross-sectional study which enrolled pregnant women attending two study hospitals between March 1993 and July 1994 was undertaken. Data on maternal socio-economic status, newborn anthropometry, previous obstetric history and current pregnancy were collected. Smoothed percentile values were derived using the LMS method. Malawian reference percentiles were constructed for fetal growth from 35 weeks' gestation for singleton births. Mean birthweight, length and head circumference were lower at all gestational ages for Malawian compared with Swedish newborns. Fetal growth per completed gestational week was higher by 60 g in weight, 0.5 cm in length and 0.2 cm in head circumference in Swedish compared with Malawian babies. Growth restriction was present from 35 to 41 weeks' gestation. The pattern for the 10th percentile suggested that this was occurring from well before 35 weeks' gestation in a proportion of babies.     

不同妊娠状态下孕妇外周血中游离胎儿DNA定量分析

目的对不同妊娠状态下孕妇外周血中游离胎儿DNA(f DNA)定量分析,确定其平均浓度及临床参考值范围,初步探讨在不同妊娠状态下母血中f DNA的浓度变化,为临床应用提供科学依据。方法从孕妇外周血浆中提取fDNA,用实时荧光定量聚合酶链反应(FQ-PCR)方法检测其中Y性别决定区的SRY基因。结果在正常早期的孕妇组38例血浆标本中有32例检测到SRY基因,其平均浓度149.25拷贝数/ml,参考值范围为33.28~265.22拷贝数/ml;在正常晚期的孕妇组32例血浆标本中全部检测到SRY基因,其平均浓度为212.14拷贝数/ml,参考值范围为142.76~281.52拷贝数/ml;在晚期患有子痫前期的孕妇30例血浆标本中全部检测到SRY基因,其平均浓度为678.70拷贝数/ml,参考值范围为595.01~726.40拷贝数/ml。实验数据用单因素方差分析,组间差异显著性检验用LSD-t检验。妊娠晚期孕妇血浆中f DNA的含量较妊娠早期升高,约为1.4倍,有统计学意义(P<0.01);晚期患子痫前期的孕妇血浆f DNA的水平是同期正常对照组的3.9倍,有统计学意义(P<0.01)。结论1.用FQ-PCR法最早在孕48天孕妇外周血中即可检测到fDNA。2.随着妊娠的进展孕妇血浆中f DNA的含量升高。3.晚期患子痫前期孕妇其血浆f DNA的水平是同期正常对照组的3.9倍,有统计学意义(P<0.01)。4.f DNA在进行无创伤性产前诊断中有重要价值。     

正常中晚期妊娠羊水板层小体增长特征及其判断胎肺成熟的意义

目的探讨羊水板层小体数量在正常中、晚期妊娠的增长规律及其对判断胎肺成熟度的意义。方法采用自动血细胞计数仪血小板通道测量310份正常单胎妊娠16～42周的无污染羊水板层小体数目。结果羊水板层小体数目在32孕周前处于低值状态,其于16、24、31孕周时中位数分别为0、5×109/L、7×109/L;满32孕周时中位数达27×109/L,后增长速度开始逐渐加快;满37孕周时中位数为147×109/L。羊水板层小体数目与孕周呈正指数曲线相关,随孕周的增加呈指数增长,相关系数（r）为0.9386,确定系数（R2）为0.881。羊水板层小体数目对孕周的指数方程为Y（LBC）＋1=0.0273e0.2201X（孕周）（P〈0.0001）。利用指数模型预测36、37、38孕周的羊水板层小体数值分别为74×109/L、92×109/L、115×109/L。结论正常中晚期妊娠羊水板层小体数量随孕周进展呈指数增长,可利用板层小体数目对孕周的指数模型对胎肺成熟度做判断。     

Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy

To elucidate the mechanism of metabolic adaptation of women with polycystic ovary syndrome (PCOS) during pregnancy, the endocrino- metabolic features of a group of PCOS patients with or without gestational diabetes were studied longitudinally during the three trimesters of gestation. Oral glucose tolerance test (OGTT, 100 g) and hyperinsulinaemic-euglycaemic clamp were performed throughout the study. Plasma concentrations of insulin and glucose were determined by radioimmunoassay and glucose oxidase technique, respectively. Five of 13 PCOS patients developed gestational diabetes (GD) at the third trimester (PCOS-GD), while the other eight patients did not develop any alteration of glucose metabolism (PCOS-nGD). Both fasting glucose and insulin plasma concentrations did not change significantly during pregnancy and no difference was seen between the two groups. On the contrary PCOS-GD group early exhibited higher values of area under the curve (AUC) for glucose and insulin response to OGTT with respect to those found in PCOS-nGD group. This difference was already significant in the first gestational trimester. Moreover insulin sensitivity value (M) was significantly lower in the first trimester of gestation in PCOS- GD as compared with that found in PCOS-nGD group. However, as gestation proceeded, M value decreased in PCOS-nDG group and the difference from PCOS patients developing gestational diabetes was not sustained into the second and third trimesters. Both groups had similar body mass index values and AUC insulin increase from first to third trimester of gestation. It is concluded that early alteration of insulin sensitivity and secretion constitute specific risk factors in PCOS patients for the development of abnormalities of glucose tolerance.      

妊娠期糖尿病胰岛素的应用

目的 研究妊娠期糖尿病（GDM）患者胰岛素应用特点.方法 分析2004年元月至2006年11月21例妊娠期糖尿病胰岛素治疗情况.结果 34周GDM患者胰岛素用量明显多于24周胰岛素用量.应用诺和灵R占66.67%,诺和灵R联合诺和灵N占33.33%（其中R-R-R-N占28.57%,N＋R-R-R-N占4.76%）.结论 妊娠期糖尿病胰岛素用量随孕周增加而变化,大部分GDM患者可采用短效胰岛素控制血糖,部分患者联用中效,不宜用长效胰岛素,分娩当天及产后减少或停用胰岛素.     

Oral contraceptives: effects on glucose and lipid metabolism in insulin-dependent diabetic women and women with previous gestational diabetes. A clinical and biochemical assessment

The obvious need for highly effective contraception in women with existing disorders of glucose metabolism has led to a search for oral contraceptive (OC) regimens for such women that are efficient but without unacceptable metabolic side effects. Recent studies have indicated that low-dose OCs can be administered to women of normal weight with previous gestational diabetes mellitus without the risk of a deterioration in glucose tolerance. The present study found that, in both women with previous gestational diabetes mellitus and normal women, triphasic OCs resulted in a significantly lower insulin response to oral glucose than the low-dose monophasic estradiol/levonorgestrel formulation. This finding suggests that the progestogen component of OCs is largely responsible for the influence of OCs on glucose homeostasis. In women of normal weight with previous gestational diabetes mellitus, there is no apparent direct association between glucose tolerance, plasma insulin levels, and insulin binding to erythrocytes and monocytes during intake of low-dose OCs; in addition, there is no adverse effect on lipid/lipoprotein levels. In women with insulin-dependent diabetes mellitus, combined OCs (estradiol-estriol/norethisterone) appear to have no adverse effects on the diabetic control; however, low-dose artificial OCs are without any influence on glycemic control in these women. Treatment with norethisterone alone appears to be an appropriate alternative to both the nonalkylated estrogen/norethisterone combinations and triphasic OCs. More longterm studies are needed regarding the effects on glucose and lipoprotein metabolism to predict the clinical significance on the occurrence of cardiovascular diseases and the deterioration of glycemic control in women with insulin-dependent diabetes and previous gestational diabetes.     

Rare detection of cytomegalovirus in severe fetal malformations in China

BackgroundCytomegalovirus (CMV) is a significant cause of fetal abnormalities in developed world. Whether this could be applied in developing world remains unknown.ObjectivesTo investigate CMV infection in severe fetal malformations in China.Study designDuring 2007–2014, 436 fetuses (237 males) with severe malformations and terminated pregnancy at median gestational age of 26⁺¹ weeks were enrolled. CMV DNA was detected in fetal kidneys and other tissues by real-time PCR, and CMV IgG and IgM were measured by ELISA.ResultsCMV DNA was positive in kidneys and other tissues of seven (1.60%) fetuses. Hematoxylin-eosin staining showed intranuclear and intracytoplasmic inclusion bodies in kidneys of three fetuses, which was also positive for CMV antigens in immunohistochemistry. CMV DNA was found in 5 (6.1%) of 82 fetuses with central nervous system anomalies, 1 (11.1%) of 9 fetuses with abdominal anomalies, 1 (0.59%) of 168 fetuses with multiple congenital malformations, and none of fetuses with other anomalies (177). Of 293 pregnant women with plasma available, 279 (95.2%) were CMV IgG positive only and 6 (2.1%) were CMV IgG and IgM positive. Of 5 mothers with infected fetuses 1 (20%) was CMV IgG and IgM positive, while 5 (1.7%) of 288 mothers with uninfected fetuses were positive respectively (P = 0.099).ConclusionsCongenital CMV infection in fetuses with severe congenital malformations is rare, indicating no close association between CMV infection and severe fetal malformations in China. Maternal screening for CMV may have minimal value in identifying fetal malformations in developing world.     

Ultrasonography-based Fetal Weight Estimation: Finding an Appropriate Model for an Indian Population

Background

Very limited information is available regarding the accuracy and applicability of various ultrasonography parameters [abdominal circumference (AC), biparietal diameter (BPD), femur length (FL), and head circumference (HC)]-based fetal weight estimation models for Indian population. The objective of this study was to systematically evaluate commonly used fetal weight estimation models to determine their appropriateness for an Indian population.

Pregnancy Outcomes Following Laparoscopic and Open Surgery in Pelvis during Pregnancy: a Nationwide Population-based Study in Korea

BackgroundNon-obstetric surgery during pregnancy is associated with adverse obstetric and fetal outcomes. The aim of this study was to investigate the risk of adverse pregnancy outcomes for women who underwent non-obstetric pelvic surgery during pregnancy compared with that of women that did not undergo surgery.MethodsStudy data from women who gave birth in Korea were collected from the Korea National Health Insurance claims database between 2006 and 2016. We identified pregnant women who underwent abdominal non-obstetric pelvic surgery by laparoscopy or laparotomy from the database. Pregnancy outcomes including preterm birth, low birth weight (LBW), cesarean section (C/S), gestational hypertension, gestational diabetes, and postpartum hemorrhage were identified. The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the pregnancy outcomes were estimated by multivariate regression models.ResultsData from 4,439,778 women were collected for this study. From 2006–2016, 9,417 women from the initial cohort underwent non-obstetric pelvic surgery (adnexal mass resection, appendectomy) during pregnancy. Multivariate logistic regression analysis indicated that preterm birth (HR, 2.01; 95% CI, 1.81–2.23), LBW (HR, 1.62; 95% CI, 1.46–1.79), C/S (HR, 1.13; 95% CI, 1.08–1.18), and gestational hypertension (HR, 1.35; 95% CI, 1.18–1.55) were significantly more frequent in women who underwent non-obstetric surgery during pregnancy compared to pregnant women who did not undergo surgery. When the laparoscopic and laparotomy groups were compared for risk of fetal outcomes, the risk of LBW was significantly decreased in laparoscopic adnexal resection during pregnancy compared to laparotomy (odds ratio, 0.62; 95% CI, 0.40–0.95).ConclusionNon-obstetric pelvic surgery during pregnancy was associated with a higher risk of preterm birth, LBW, gestational hypertension, placenta previa, placental abruption, and C/S. Although the benefits and safety of laparoscopy during pregnancy appear similar to those of laparotomy in regard to pregnancy outcomes, laparoscopic adnexal mass resection was associated with a lower risk of LBW.     

Type 2 diabetes control and complications and their relation to serum magnesium level

IntroductionType 2 diabetes (T2D) is a growing health problem nationally and worldwide. Magnesium is an important mineral that is essential for a wide range of metabolic reactions. Here, our primary goal was to determine the prevalence of hypomagnesemia and its relationship to glycemic control, cardiovascular markers, and T2D-related complications.Material and methodsA cross-sectional study was performed from September 2015 to March 2017 including adult patients with T2D who attended the Endocrine and Diabetes Center, Taif, Saudi Arabia. Those with known hypomagnesemia, patients with type 1 diabetes, gestational diabetes, patients with end-stage renal disease, and those on magnesium supplementations were excluded. Those with a serum magnesium level < 0.7 mmol/l were considered to have hypomagnesemia. Otherwise, patients were considered to have a normal serum Mg level.ResultsA total of 285 patients with a mean age of 59.4 ±12.7 years were enrolled. The majority of patients were female, with long-standing T2D, with a mean body mass index in the obesity category, and most of them had comorbid conditions. Twenty-eight percent of the screened T2D patients had hypomagnesemia and this group were more likely to have a bachelor degree (p = 0.034), to be on metformin, statin, and glargine insulin (all p < 0.05), have worse glycemic control (p < 0.05), and a higher pulse rate (p = 0.039), but were less likely to be on diet control (p = 0.034) when compared to those with a normal Mg level.ConclusionsAlmost one-third of the screened T2D patients have hypomagnesemia. Hypomagnesemia was associated with the treatment modalities, worse glycemic control, and with peripheral artery disease.     

Fetal Growth and Adipose Fat Tissue Trajectories in Twin Pregnancies after Gastric Bypass Surgery

IntroductionPrevious studies demonstrated a continuous decline in fetal growth throughout singleton pregnancy after bariatric surgery. However, intrauterine growth in twin pregnancy is subjected to further underlying processes. This study was to investigate the longitudinal assessment of fetal biometry and abdominal fat thickness of twin pregnancies conceived after gastric bypass (GB) surgery and compare them to body mass index-matched (BMIM) and obese (OB) controls.Materials and MethodsWe retrospectively assessed ultrasound data of 30 women with dichorionic-diamniotic twin pregnancy (11 women after GB surgery, 9 OB mothers with pregestational BMI ≥30 kg/m², and 10 BMIM and age-matched controls). We assessed fetal growth parameters including fetal subcutaneous adipose tissue thickness (FSCTT) as well as newborn biometry after delivery. Patient characteristics were obtained from the medical records.ResultsThe rise in FSCTT curves was markedly slower in the twin offspring of women with history of GB as compared to the offspring of OB mothers and offspring of BMIM controls. Hence, FSCTT was significantly decreased in the GB offspring as compared to both control groups at 34 weeks of gestation. Also, growth curves of abdominal circumference were decreased in the offspring of GB patients as compared to OB mothers. Infants of mothers with history of GB showed significantly lower birth weight percentiles compared to newborns of OB mothers (27.2 vs. 48.8 pct, p = 0.025). There was no significant difference in inter-twin birth weight difference between the offspring of GB (median: 9.9%, interquartile ranges [IQR]: 6.5–20.0) versus OB (median: 14.6%, IQR: 8.2–21.6) and BMIM controls (median: 9.0%, IQR: 6.3–12.6, p = 0.714).ConclusionsIn summary, intrauterine growth delay in twin pregnancies after GB is assumed to be a multifactorial event with altered metabolism as the most important factor. However, special attention must be paid to the particularity of twin pregnancies as they seem to be subject to other additional mechanism.     

Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe

Cell-free fetal DNA in maternal plasma or serum is at present widely investigated as a source of fetal genetic material, both in studies of pregnancy-related disorders and in planning strategies for non-invasive prenatal diagnosis. Despite the number of trials already performed on the quantitation of fetal DNA, data about the amount of DNA at the beginning of pregnancy, in particular in the first trimester, remain limited. A new probe mapping on the deleted in azoospermia (DAZ) repetitive region of the Yq chromosome was designed for an early assessment of fetal DNA concentration in maternal serum. Among 57 pregnant women prospectively studied in their first trimester, fetal DNA was detected already by the 5th gestational week, with the analysis becoming reliable by the 8th week of gestation when a 100% accuracy in fetal sex determination was achieved. Moreover, in the three cases of pregnancy ending in fetal loss, the amount of fetal DNA apparently decreased before the abortion was diagnosed, whereas it consistently showed an increasing trend in normal pregnancies. Real-time PCR with the use of DAZ multilocus probe can efficiently quantitate free fetal DNA in the maternal serum at the beginning of pregnancy.     

Increased serum insulin-like growth factor-1 levels in women with gestational diabetes

BackgroundInsulin-like growth factor-1 (IGF-1), which has effects similar to insulin, reduces blood glucose level, improves insulin sensitivity and may play an important role in the pathogenesis of gestational diabetes (GDM).ObjectiveThe aim of the study was to estimate the concentration of IGF-1 in pregnant women with GDM and 3 months after delivery and find relationships between IGF-1 and clinical and biochemical parameters.Materials and methods67 women between 24th - 28th week of pregnancy were enrolled in the study (46 with GDM and 21 as a control group). All women underwent clinical and biochemical examinations. Concentrations of IGF-1, adiponectin, fasting glucose, insulin, lipids, CRP, fibrinogen were measured during pregnancy, additionally IGF-1 concentration was determined 3 months after delivery.ResultsIGF-1, glucose, insulin, CRP, fibrinogen, lipids concentrations and HOMA-IR were significantly higher in women with GDM than in the control group (p<0.05). A significant decrease in IGF-1 concentration was observed in both groups after delivery. In the GDM group significant correlations between IGF-1 and BMI (r=0.370, p<0.05), insulin (r=0.469, p<0.01) and HOMA-IR (r=0.439, p<0.01) were observed. Regression analysis with IGF-1 as a dependent parameter showed that only BMI and insulin remained as predictors, explaining 32% of plasma IGF-1 variation. Re-evaluation after delivery revealed impaired glucose tolerance in 9% of the population studied.ConclusionsIncreased IGF-1 concentrations in pregnancy complicated with GDM may partly reflect metabolic disturbances, especially insulin resistance and hyperinsulinemia, and may be one of possible compensatory reactions of the organism in response to these disturbances.